Dipna Pharmachem

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0MC401013
  • NSEID:
  • BSEID: 543594
INR
9.85
0.6 (6.49%)
BSENSE

Mar 20

BSE+NSE Vol: 57000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1003693,
    "name": "Dipna Pharmachem",
    "stock_name": "Dipna Pharmachem",
    "full_name": "Dipna Pharmachem Ltd",
    "name_url": "stocks-analysis/dipna-pharmachem",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "9.85",
    "chg": 0.6,
    "chgp": "6.49%",
    "dir": 1,
    "prev_price": "9.25",
    "mcapval": "24.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 543594,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE0MC401013",
    "curr_date": "Mar 20",
    "curr_time": "",
    "bse_nse_vol": 57000,
    "exc_status": "Active",
    "traded_date": "Mar 20, 2026",
    "traded_date_str": "2026 03 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/dipna-pharmachem-1003693-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 91,
    "sid": "1003693",
    "stock_news_url": "https://www.marketsmojo.com/news/dipna-pharmachem-1003693"
  },
  "announcements": [
    {
      "caption": "Clarification sought from Dipna Pharmachem Ltd",
      "datetime": "23-Feb-2026",
      "details": "The Exchange has sought clarification from Dipna Pharmachem Ltd on February 23 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.",
      "source": "BSE"
    },
    {
      "caption": "Announcement Under Regulation 30 (LODR)- Intimation Of Trading Approval Received For 2244000/- Equity Shares.",
      "datetime": "21-Jan-2026",
      "details": "Intimation of Trading approval received for 2244000/- equity shares.",
      "source": "BSE"
    },
    {
      "caption": "Clarification Sought On Significant Movement In Price",
      "datetime": "21-Jan-2026",
      "details": "Clarification Sought on significant movement in price",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Dipna Pharmachem Ltd has announced <strong>13:12</strong> rights issue, ex-date: 12 Feb 24",
          "dt": "2024-02-12",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}
stock newsNews and Views
Icon
No Recent News for the Company
stock-recommendationAnnouncement

Clarification sought from Dipna Pharmachem Ltd

23-Feb-2026 | Source : BSE

The Exchange has sought clarification from Dipna Pharmachem Ltd on February 23 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.

The reply is awaited.

Announcement Under Regulation 30 (LODR)- Intimation Of Trading Approval Received For 2244000/- Equity Shares.

21-Jan-2026 | Source : BSE

Intimation of Trading approval received for 2244000/- equity shares.

Clarification Sought On Significant Movement In Price

21-Jan-2026 | Source : BSE

Clarification Sought on significant movement in price

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

Dipna Pharmachem Ltd has announced 13:12 rights issue, ex-date: 12 Feb 24